Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

NPO Petrovax · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
diseasefibrosislung
post-acute covid-19 syndrome, lung disease with polymyositis, fibrosis, lung diseases, interstitial, lung; disease, interstitial, with fibrosis, lung diseases, covid-19, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1010838
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.